-
Founded in:
2004-04-07 -
Country:
China -
Address:
No. 2, Yaogu Sanheng Road, Yaogu Industrial Park, Haikou National High-tech Zone -
Tax NO.:
91460100754396590D -
Registered Funds:
150 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Thymopentin |
An immune bidirectional regulatory drug that induces and promotes the differentiation, maturation and activation of T lymphocytes and their subsets, regulates the proportion of T lymphocytes, enhances the body's cellular immune function, prompts T lymphocytes to secrete lymphokines, increases the level of lymphokine receptors on T cells, activates T helper cells to enhance lymphocyte responses, affects the chemotaxis of NK precursor cells and increases their cytotoxicity, and enhances the body's ability to resist radiation.
More
An immune bidirectional regulatory drug that induces and promotes the differentiation, maturation and activation of T lymphocytes and their subsets, regulates the proportion of T lymphocytes, enhances the body's cellular immune function, prompts T lymphocytes to secrete lymphokines, increases the level of lymphokine receptors on T cells, activates T helper cells to enhance lymphocyte responses, affects the chemotaxis of NK precursor cells and increases their cytotoxicity, and enhances the body's ability to resist radiation. |
69558-55-0 | 41 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Carbazochrome sodium sulfonate |
It can reduce capillary permeability, enhance the retraction effect of broken capillary ends, and increase the resistance of capillaries to damage. It is often used for various types of bleeding caused by increased capillary permeability.
More
It can reduce capillary permeability, enhance the retraction effect of broken capillary ends, and increase the resistance of capillaries to damage. It is often used for various types of bleeding caused by increased capillary permeability. |
51460-26-5 | 33 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Lansoprazole |
A specific description of the pharmacological action cannot be unambiguously extracted from the above information.
More
A specific description of the pharmacological action cannot be unambiguously extracted from the above information. |
103577-45-3 | 87 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Nimodipine |
Extract from the above information
More
Extract from the above information |
66085-59-4 | 17 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Risperidone |
Not yet clear
More
Not yet clear |
106266-06-2 | 54 |